UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 __________________________ THE PENNANT GROUP, INC. (Exact Name of Registrant as Specified in Its Cha ...

Pennant Group, Inc. (NASDAQ:PNTG) Q4 2023 Earnings Conference Call February 29, 2024 12:00 PM ET Company Participants Kirk Cheney - General Counsel & Corporate Secretary Brent Guerisoli - CEO & Director John Gochnour - President & COO Lynette Walbom - CFO Conference Call Participants Dean Sublett - Stephens, Inc. Operator Good day, and thank you for standing by. Welcome to the Pennant Group Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is bei ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2023. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 _____ ...

Fourth Quarter Highlights 1 Exhibit 99.1 Pennant Reports Fourth Quarter and Fiscal Year 2023 Results Conference Call and Webcast scheduled for tomorrow, February 29, 2024 at 10:00 am MT EAGLE, Idaho – February 28, 2024 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the fiscal year and fourth quarter of 2023, reporting GAAP diluted earnings per share of ...

Pennant Group, Inc. (NASDAQ:PNTG) Q3 2023 Earnings Conference Call November 8, 2023 12:00 PM ET Company Participants Kirk Cheney - General Counsel & Corporate Secretary Brent Guerisoli - CEO & Director John Gochnour - President & COO Lynette Walbom - CFO Conference Call Participants Benjamin Hendrix - RBC Capital Markets Operator Good day, and thank you for standing by. Welcome to the Pennant Group Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. Please be advised that today's conferenc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2023. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 __________________________ THE PENNANT GROUP, INC. (Exact Name of Registrant as Specified in Its ...

The Pennant Group Inc. (NASDAQ:PNTG) Q2 2023 Results Conference Call August 9, 2023 12:00 PM ET Company Participants Kirk Cheney - General Counsel and Corporate Secretary Brent Guerisoli - Chief Executive Officer John Gochnour - President and COO Lynette Walbom - Chief Financial Officer Conference Call Participants Raj Kumar - Stephens Ben Hendrix - RBC Capital Markets Operator Good day, and thank you for standing by. Welcome to the Pennant Group Second Quarter 2023 earnings conference call. At this time, a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of (I.R.S. Employer Washington, D.C. 20549 _____________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2023. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-389 ...

Financial Data and Key Metrics Changes - The company reported consolidated revenue of $126.5 million for Q1 2023, an increase of $12.6 million or 11% compared to the prior year quarter [26] - Adjusted EBITDA for the quarter was $7.9 million, reflecting an increase of $1.8 million or 28.8% over the prior year quarter [26] - GAAP diluted earnings per share increased by 50% to $0.06, while non-GAAP diluted earnings per share rose by 18.2% to $0.13 [52] Business Line Data and Key Metrics Changes - Home health and hospice revenue for the quarter was $91.1 million, up $10.6 million or 13.2% year-over-year, with adjusted EBITDA of $13.2 million, a 3.7% increase [39] - Senior living segment revenue improved to $34.6 million, an increase of $4.5 million or 15% over the prior year quarter, with adjusted EBITDA rising to $2.3 million, a 45.6% increase [46] Market Data and Key Metrics Changes - Home health admissions increased by 7.1% and Medicare home health admissions rose by 6.8% compared to the prior year quarter [40] - Same-store senior living occupancy reached 79.1%, a 370 basis point improvement year-over-year [47] Company Strategy and Development Direction - The company is focused on five key organizational priorities: leadership development, margin improvement, turnover reduction, growth, and clinical excellence [27] - A commitment to develop 100 local CEOs is underway, with seven local CEOs appointed year-to-date [28] - The company aims to optimize operations and increase margins through careful measurement of utilization and staff productivity [30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving 2023 earnings commitments despite ongoing inflationary pressures and labor challenges [25] - The company anticipates continued growth in home health and hospice segments throughout 2023, driven by strong clinical outcomes and community engagement [42] Other Important Information - The company has made significant progress in reducing employee turnover, achieving double-digit year-over-year improvements, particularly in the senior living business [32] - The company completed one license acquisition in Q1 2023, expanding its continuum of care in Prescott, Arizona [50] Q&A Session Summary Question: What are the company's views on the Medicaid services proposal and its exposure to home care services? - Management indicated a modest exposure to home care, which is a growing segment but represents a small portion of overall home health revenue [61][62]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-Q 1675 East Riverside Drive, Suite 150, Eagle, ID 83616 (Address of Principal Executive Offices and Zip Code) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2023. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 00 ...